Buchler GmbH
  • Products
    • Active Pharmaceutical Ingredients
    • Asymmetric Synthesis
      • Chiral Building Blocks
      • Chiral Phase Transfer Catalysts (PTCs)
      • Chiral Screening Kit
      • Enantioselective Organocatalysts
      • Racemic Resolution
    • Food Ingredients
    • Product Overview
  • Chiral Catalyst Search (NEW)
  • Contact
  • About
    • Certificates
    • Company Policy
    • Former Buchler Company Managers
    • Galleries
      • Gallery current production and storage
      • Gallery Laboratory
      • Gallery Historical Production
    • History of Buchler
  • Career
Select Page

Semipinacol Rearrangement, disubstituted (3,4-dihydro-2H-pyran-6-yl)methanol, N-Bromoacetamide, 1,3-Dichloro-5,5-diphenyl-2,4-imidazolidinedione, chiral α-oxa-quaternary β-haloketones, (9S,9′′S)-9,9′′-[(2,5-diphenyl-4,6-pyrimidinediyl)bis(oxy)]bis[10,11-dihydro-6′-methoxy-cinchonan], Dihydroquinidine Derivative

by werner@buchler-gmbh.com | Jul 13, 2023

Chlorocyclization, unsaturated amides, 1,3-dichloro-5,5-dimethylimidazolidine-2,4-dione, (2,5R)-substituted 5-(chloromethyl)-4,5-dihydrooxazole, 1,4-Bis(9-O-dihydroquinidinyl)phthalazine, Dihydroquinidine Derivative

by werner@buchler-gmbh.com | Jul 7, 2023

Amination, masked ammonia, Morita–Baylis–Hillman carbonates, 3R-substituted 3-(((diphenylmethylene)amino)methyl)but-3-en-2-one, 1,4-Bis[(9S)-10,11-dihydro-6′-methoxycinchonan-9-yl]-9,10-anthracenedione, Dihydroquinidine Derivative

by werner@buchler-gmbh.com | Jul 4, 2023

Aldol reaction, methyl 2-isocyano-2-phenylacetate, 3-fluorobenzaldehyde, methyl (4R,5R)-5-(3-fluorophenyl)-4-phenyl-4,5-dihydrooxazole-4-carboxylate, silver(I) oxide, N-[(9R)-10,11-dihydrocinchonan-9-yl]-2-(diphenylphosphino)-benzamide, Dihydroquinidine Derivative

by werner@buchler-gmbh.com | Jun 28, 2023

Spirocyclization, oxindoles, bromonitromethane, substituted tert-butyl (1R,2R,3S)-3-nitro-2′-oxospiro[cyclopropane-1,3′-indoline]-1′-carboxylate, N-[3,5-bis(trifluoromethyl)phenyl]-N′-[(9R)-10,11-dihydro-6′-methoxycinchonan-9-yl]-thiourea, Dihydroquinidine Derivative

by werner@buchler-gmbh.com | Jun 28, 2023

« Older Entries
Next Entries »

Glossary

Impressum / Legal Notice

Code of Conduct

Hinweisgebersystem / Whistleblowing System

Allgemeine Geschäfts-bedingungen / General Terms and Conditions

Datenschutzhinweise / Data Protection Information

Contact

My Account
  • Follow
  • Follow

All Rights Reserved by Buchler GmbH